House and Senate Approve FDA Reform Bill

The U.S. Senate and House of Representatives have approved separate bills that would revise FDA’s ability to oversee certain provisions related to pharmaceutical ingredients and includes a generic drug user fee program. The bills will now move to a House and Senate conference to reconcile differences in the two versions. The legislation, if finalized by Congress, would represent a significant victory for Socma, which for years has been urging lawmakers to take steps to make sure U.S. makers of active pharmaceutical ingredients (APIs) do not face unfair...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers